Buscar resultados de ensayos clínicos
Hyperplasia - 271 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia Condición:
Fecha: 2013-11-28 Intervenciones:
|
Completed |
Nombre del estudio: Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia Condición:
Fecha: 2001-02-28 |
Completed |
Nombre del estudio: Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia Condición:
Fecha: 1999-11-03 Intervenciones:
|
Recruiting |
Nombre del estudio: Prenatal Dex Study Condición: Congenital Adrenal Hyperplasia Fecha: 2016-05-25 Intervenciones: Behavioral: Neuropsychological and cognitive assessment |
Completed |
Nombre del estudio: Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets Condición: Congenital Adrenal Hyperplasia Fecha: 1999-11-03 Intervenciones: Drug: Nifedipine |
Recruiting |
Nombre del estudio: A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH Condición: Congenital Adrenal Hyperplasia Fecha: 2016-08-22 Intervenciones: Drug: Hydrocortisone Modified release hydrocortisone |
Completed |
Nombre del estudio: Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia Condición:
|
Completed |
Nombre del estudio: Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia Condición:
|
Active, not recruiting |
Nombre del estudio: A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease Condición: Multicentric Castleman's Disease Fecha: 2011-04-21 Intervenciones: Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous. |
Completed |
Nombre del estudio: A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment Condición: Castleman's Disease Fecha: 2010-08-13 Intervenciones: Drug: tocilizumab [RoActemra/Actemra] maintenance dose |